Author

Ashley J. Birkett

Program for Appropriate Technology in HealthORCID 0000-0002-0455-2908Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Assay:proteomics· 2 Organism:rat· 2 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Amelia M. LiasiD· 2 shared Amy R. NoeiD· 2 shared Barnabas G. WilliamsiD· 2 shared C. Richter KingiD· 2 shared Carole A. LongiD· 2 shared Cassandra A. RigbyiD· 2 shared Cecilia CarnrotiD· 2 shared David J. PattinsoniD· 2 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Amelia M. LiasORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyCell Reports MedicinePeer-reviewedJul 1, 2024

Preclinical Development of a Stabilized RH5 Virus-Like Particle Vaccine that Induces Improved Anti-Malarial Antibodies

Lloyd D. W. King, David Pulido, Jordan R. Barrett…·Simon J. Draper

This paper develops a stabilized RH5 VLP vaccine that induces improved anti-malarial antibodies compared to a soluble protein vaccine in preclinical studies.

31 citationstop 1%

humanrat

𝕏 PostBluesky

ImmunologyNature CommunicationsPeer-reviewedJun 7, 2024

Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex

Barnabas G. Williams, Lloyd D. W. King, David Pulido…·Simon J. Draper

This paper develops a combination malaria vaccine targeting the RCR-complex by fusing epitopes from RIPR to CyRPA, improving in vitro growth inhibition compared to RH5.1 alone.

34 citationstop 1%

ratproteomics

𝕏 PostBluesky